Continuing the patent dispute internationally, China has now given the Charpentier/Doudna side a patent to edit genes in the country.
CRISPR pioneers Emmanuelle Charpentier and Jennifer Doudna lost a patent case to the Broad Insititute earlier this year when the court determined the Broad Insititute had an application markedly different than Charpentier’s and Doudna’s overall patent. Read More

…read more

Source:: TechCrunch

(Visited 5 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *